← Back to Clinical Trials
Recruiting NCT07453615

NCT07453615 Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07453615
Status Recruiting
Phase
Sponsor Antalya Training and Research Hospital
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-03-15
Primary Completion 2026-07-15

Trial Parameters

Condition Anxiety
Sponsor Antalya Training and Research Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 4 Years
Max Age 10 Years
Start Date 2026-03-15
Completion 2026-07-15
Interventions
AI-Generated Storytelling VideoStandard Clinic Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). The study aims to determine if watching a cognitive preparation video at home prior to the appointment reduces anxiety compared to standard care. Participants will be randomized into two groups: an intervention group watching the AI-generated video and a control group receiving standard clinic care

Eligibility Criteria

Inclusion Criteria: * Children aged between 4 and 10 years (from 4th birthday to 11th birthday). * Children undergoing a Skin Prick Test (SPT) for the first time. * Presence of suspected Allergic Rhinitis and/or Asthma. * Cognitive ability to understand Turkish, follow the video story, and interpret visual assessment scales. * Parents with internet access to view the digital content. * Obtained parental informed consent and child assent (for ages 7 and above) Exclusion Criteria: * Previous experience with Skin Prick Testing or a history of frequent medical procedures (e.g., frequent blood draws, surgeries) due to chronic illness. * Diagnosed with Autism Spectrum Disorder, severe ADHD(attention deficit hyperactivity disorder), intellectual disability, or severe psychiatric conditions preventing cooperation. * Significant visual or hearing impairments that prevent engagement with the video content. * Use of anxiolytics, sedatives, or medications affecting cognitive functions within the l

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology